Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement.


Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
Sep 2021
Historique:
pubmed: 19 7 2021
medline: 12 11 2021
entrez: 18 7 2021
Statut: ppublish

Résumé

Worldwide, there are 657 million women aged 45-59 and around half contribute to the labor force during their menopausal years. There is a diversity of experience of menopause in the workplace. It is shaped not only by menopausal symptoms and context but also by the workplace environment. It affects quality of life, engagement, performance, motivation and relations with employers. To provide recommendations for employers, managers, healthcare professionals and women to make the workplace environment more menopause supportive, and to improve women's wellbeing and their ability to remain in work. Literature review and consensus of expert opinion. Workplace health and wellbeing frameworks and policies should incorporate menopausal health as part of the wider context of gender and age equality and reproductive and post-reproductive health. Workplaces should create an open, inclusive and supportive culture regarding menopause, involving, if available, occupational health professionals and human resource managers working together. Women should not be discriminated against, marginalized or dismissed because of menopausal symptoms. Health and allied health professionals should recognize that, for some women, menopausal symptoms can adversely affect the ability to work, which can lead to reduction of working hours, underemployment or unemployment, and consequently financial insecurity in later life.

Identifiants

pubmed: 34274202
pii: S0378-5122(21)00107-9
doi: 10.1016/j.maturitas.2021.06.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-62

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Margaret Rees (M)

Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. Electronic address: margaret.rees@st-hildas.ox.ac.uk.

Johannes Bitzer (J)

Department of Obstetrics and Gynecology, University Hospital, Basel, Switzerland.

Antonio Cano (A)

Department of Pediatrics, Obstetrics and Gynecology, University of Valencia and INCLIVA, Valencia, Spain.

Iuliana Ceausu (I)

Department of Obstetrics and Gynecology I, Carol Davila" University of Medicine and Pharmacy, "Dr. I. Cantacuzino" Clinical Hospital, Bucharest, Romania.

Peter Chedraui (P)

Instituto de Investigación e Innovación en Salud Integral (ISAIN), Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador.

Fatih Durmusoglu (F)

İstanbul Medipol International School of Medicine, Istanbul, Turkey.

Risto Erkkola (R)

Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland.

Marije Geukes (M)

Department of Obstetrics and Gynecology, Ziekenhuisgroep Twente (Hospital Group Twente), Post box 7600, 7600 SZ Almelo, Netherlands.

Alan Godfrey (A)

Department of Computer and Information Sciences, Northumbria University, Newcastle upon Tyne, NE1 8ST, United Kingdom.

Dimitrios G Goulis (DG)

Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece.

Amanda Griffiths (A)

School of Medicine, University of Nottingham, Nottingham NG7 2TU, United Kingdom.

Claire Hardy (C)

Division of Health Research, Faculty of Health and Medicine, Lancaster University Lancaster, LA1 4AT, United Kingdom.

Martha Hickey (M)

Department of Obstetrics and Gynecology, University of Melbourne, Parkville, Australia; The Royal Women's Hospital, Victoria, Australia.

Angelica Lindén Hirschberg (AL)

Department of Women's and Children's Health, Karolinska Institutet and Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.

Myra Hunter (M)

Institute of Psychiatry, Psychology and Neuroscience,Kings College London, London SE1 9RT, United Kingdom.

Ludwig Kiesel (L)

Departmen of Gynecology and Obstetrics, University of Münster, Münster, Germany.

Gavin Jack (G)

Monash Business School, Monash University, Caulfield East VIC 3145, Australia.

Patrice Lopes (P)

Polyclinique de l'Atlantique Saint Herblain. F 44819 St Herblain France, Université de Nantes F 44093 Nantes Cedex. France.

Gita Mishra (G)

School of Public Health, The University of Queensland, Brisbane, Australia.

Henk Oosterhof (H)

Werkindeovergang Consultancy, Lange Singel 24, 9243KJ Bakkeveen, Netherlands.

Amos Pines (A)

Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Kathleen Riach (K)

Adam Smith Business School, University of Glasgow, Glasgow G12 8QQ, United Kingdom.

Chrisandra Shufelt (C)

Barbra Streisand Women's Heart Center, Cedars-Sinai Medical Center, Los Angeles CA 90048, United States.

Mick van Trotsenburg (M)

Department of Obstetrics and Gynecology, University Hospital St. Poelten-Lilienfeld, Austria.

Rachel Weiss (R)

Menopause Café charity, c/o Rowan, 4 Kinnoull Street, Perth PH1 5EN, United Kingdom.

Irene Lambrinoudaki (I)

Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH